It's just a question for you of which comes first. The news that will see a real appreciation in the SP (TAVR deal, or ADAPT sale increase), news that gives AHZ a bit more time (infusion sale) or a CR and/or next 4c showing cash burn as per usual.
Good luck with it, it's a gamble either way in my view but I fear the latter is more likely than the former going on past experience. I'm pretty skeptical of the recent price rise also, doesn't add up to me.
You deserve to get lucky at least once with this thing though Iceman.
Ann: Trading Halt, page-25
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |